OMOP Concept 740240
10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza]
StandardDrugRxNorm2474244Quant Branded Drug
Maps from
2
Descendants
0
Valid from
5 Apr 2021
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
2 source codes normalize to 10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza] via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| NDC | 730420201 | naxitamab 40mg/10mL INTRAVENOUS INJECTION | Non-standard |
| NDC | 73042020101 | 10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza] | Non-standard |
Synonyms
Alternative names recorded for 10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza] across source vocabularies.
- 10 ML Danyelza 4 MG/ML Injection
- Danyelza 40 MG per 10 ML Injection
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(19)Roll up to these when you need a wider cohort.
- 1Danyelza Injectable Product
- 1naxitamab-gqgk 4 MG/ML
- 1naxitamab-gqgk 4 MG/ML [Danyelza]
- 1naxitamab Injectable Product
- 1naxitamab Injection
- 1naxitamab Injection [Danyelza]
- 2DANYELZA - naxitamab injection
- 2Injectable Product
- 2naxitamab
- 2naxitamab
- 3Anti-GD2 antibody
- 3Other monoclonal antibodies and antibody drug conjugates
- 4Antineoplastic monoclonal antibody
- 4MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
- 5Antibody medication
- 5ANTINEOPLASTIC AGENTS
- 5Targeted therapeutic
- 6ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- 6Antineoplastics by class effect
Get this concept via the API
Resolve 10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/740240?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card